Lifestyle intervention can be effective when treating non-alcoholic fatty liver diseases
(NAFLD) patients. Weight loss decreases cardiovascular and diabetes risk and can also …

A complex antioxidant system has been developed in mammals to relieve oxidative stress.
However, excessive reactive species derived from oxygen and nitrogen may still lead to …

Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …

Reactive oxygen and nitrogen species (RONS) are essential for normal physiological
processes and play important roles in cell signaling, immunity, and tissue homeostasis …

With nonalcoholic steatohepatitis (NASH), NASH cirrhosis, and NASH-related hepatocellular
carcinoma becoming increasingly prevalent, the need for effective therapies has never been …

Reactive oxygen species (ROS) are widely believed to cause or aggravate several human
pathologies such as neurodegenerative diseases, cancer, stroke and many other ailments …

NASH is becoming increasingly common worldwide because of the growing global
prevalence of obesity and consequently NAFLD. Unfortunately, the mechanism of …

Reactive oxygen species, when released under controlled conditions and limited amounts,
contribute to cellular proliferation, senescence, and survival by acting as signaling …

Objectives Vitamin E is often used in the treatment of nonalcoholic fatty liver disease
(NAFLD), including nonalcoholic steatohepatitis (NASH); however, the magnitude of …

Non-alcoholic fatty liver disease (NAFLD) represents the most common and emerging
chronic liver disease worldwide. It includes a wide spectrum of liver diseases ranging from …